These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 36825382)
1. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 Wang M; Zhai R; Wang M; Zhu W; Zhang J; Yu M; Zhang W; Ye J; Liu L Mol Oncol; 2023 Aug; 17(8):1514-1530. PubMed ID: 36825382 [TBL] [Abstract][Full Text] [Related]
2. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038 [TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
6. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response. Sadeghirad H; Monkman J; Tan CW; Liu N; Yunis J; Donovan ML; Moradi A; Jhaveri N; Perry C; Adams MN; O'Byrne K; Warkiani ME; Ladwa R; Hughes BGM; Kulasinghe A J Transl Med; 2024 Jul; 22(1):677. PubMed ID: 39049036 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma. Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289 [TBL] [Abstract][Full Text] [Related]
10. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y Front Immunol; 2023; 14():1096220. PubMed ID: 36776859 [TBL] [Abstract][Full Text] [Related]
11. Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma. Zhang B; Li H; Liu YT; Xiong D; Zhang L; Sun ZJ Cancer Lett; 2023 Apr; 558():216105. PubMed ID: 36841416 [TBL] [Abstract][Full Text] [Related]
12. Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma. Zhao H; Zhao Y; Zhang S; Wang Z; Yu W; Dong N; Yang X; Zhang X; Sun Q; Hao X; Ren X Front Immunol; 2024; 15():1302751. PubMed ID: 38384466 [TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma. Li R; Huang X; Yang W; Wang J; Liang Y; Zhang T; Mao Q; Xia W; Xu L; Xu X; Dong G; Jiang F J Pathol Clin Res; 2022 Sep; 8(5):422-435. PubMed ID: 35711130 [TBL] [Abstract][Full Text] [Related]
14. Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Zhang XY; Shi JB; Jin SF; Wang RJ; Li MY; Zhang ZY; Yang X; Ma HL Cancer Commun (Lond); 2024 Jun; 44(6):670-694. PubMed ID: 38734931 [TBL] [Abstract][Full Text] [Related]
15. CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma. Lin X; Zhao X; Chen Y; Yang R; Dai Z; Li W; Lin C; Cao W Int J Immunopathol Pharmacol; 2024; 38():3946320241227312. PubMed ID: 38252495 [No Abstract] [Full Text] [Related]
16. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Ruffin AT; Cillo AR; Tabib T; Liu A; Onkar S; Kunning SR; Lampenfeld C; Atiya HI; Abecassis I; Kürten CHL; Qi Z; Soose R; Duvvuri U; Kim S; Oesterrich S; Lafyatis R; Coffman LG; Ferris RL; Vignali DAA; Bruno TC Nat Commun; 2021 Jun; 12(1):3349. PubMed ID: 34099645 [TBL] [Abstract][Full Text] [Related]
17. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma. Bao J; Betzler AC; Hess J; Brunner C Front Immunol; 2023; 14():1233085. PubMed ID: 37868967 [TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters. Zeng L; Koh VCY; Chen XY; Tan PH Histopathology; 2023 Apr; 82(5):779-788. PubMed ID: 36635954 [TBL] [Abstract][Full Text] [Related]
19. Tertiary lymphoid structures in the era of cancer immunotherapy. Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904 [TBL] [Abstract][Full Text] [Related]
20. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer. Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]